Remember Me
Or use your Academic/Social account:


Or use your Academic/Social account:


You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.


Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message


Verify Password:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Wannamethee, S. Goya; Whincup, Peter H.; Papacosta, Olia; Lennon, Lucy; Lowe, Gordon D. (2017)
Publisher: Elsevier
Journal: International Journal of Cardiology
Languages: English
Types: Article
Subjects: Heart failure, Cardiology and Cardiovascular Medicine, D-dimer, Coagulation, Article, NT-proBNP
Aims: \ud \ud Chronic heart failure (HF) is associated with activation of blood coagulation but there is a lack of prospective studies on the association between coagulation markers and incident HF in general populations. We have examined the association between the coagulation markers fibrinogen, von Willebrand Factor (VWF), Factors VII, VIII and IX, D-dimer, activated protein C (APC) and activated partial thromboplastin time (aPPT) with NT-proBNP and incident HF.\ud \ud Methods and results: \ud \ud Prospective study of 3366 men aged 60–79 years with no prevalent HF, myocardial infarction or venous thrombosis and who were not on warfarin, followed up for a mean period of 13 years, in whom there were 203 incident HF cases. D-dimer and vWF were significantly and positively associated with NT-proBNP (a marker of neurohormonal activation and left ventricular wall stress) even after adjustment for age, lifestyle characteristics, renal dysfunction, atrial fibrillation (AF) and inflammation (C-reactive protein). By contrast Factor VII related inversely to AF and NT-proBNP even after adjustment. No association was seen however between the coagulation markers VWF, Factor VII, Factor VIII, Factor IX, D-dimer, APC resistance or aPPT with incident HF in age-adjusted analyses. Fibrinogen was associated with incident HF but this was abolished after adjustment for HF risk factors.\ud \ud Conclusion: \ud \ud Coagulation activity is not associated with the development of HF. However D-dimer and vWF were significantly associated with NT-proBNP, suggesting that increased coagulation activity is related to cardiac stress; and the increased coagulation seen in HF patients may in part be a consequence of neurohormonal activation.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • grant RG/13/16/30528. [1] A. Mongirdiene, L. Kursvietiene, A. Kasauskas, The coagulation system changes in
    • patients with chronic heart failure, Medicina (Kaunas) 46 (9) (2010) 642-647. [2] C.J. Davis, P.A. Gurbel, W.A. Gattis, S.Y. Fuzaylov, G.V. Nair, C.M. O'Connor, V.L.
    • diagnostic significance and clinical challenge, Int. J. Cardiol. 75 (2000) 15-21. [3] M. Cugno, D. Mari, P.L. Meroni, E. Gronda, F. Vicari, M. Frigerio, R. Coppola, B.
    • transplantation, Br. J. Haematol. 126 (2004) 85-92. [4] B. Jug, N. Vene, B.G. Salobir, M. Sebestjen, M. Sabovic, I. Keber, Procoagulant state in
    • heart failure with preserved left ventricular ejection fraction, Int. Heart J. 50 (2009)
    • 591-600. [5] B.S. Chin, A.D. Blann, C.R. Gibbs, N.A. Chung, D.G. Conway, G.Y. Lip, Prognostic value
    • of interleukin-6, plasma viscosity, fibrinogen, von Willebrand factor, tissue factor
    • Investig. 33 (2003) 941-948. [6] A. Alonso, W. Tang, S.K. Agarwal, E.Z. Soliman, A.M. Chamberlain, A.R. Folsom,
    • the ARIC study, Int. J. Cardiol. 155 (2012) 217-222. [7] Fibrinogen Studies Collaboration, Plasma fibrinogen level and the risk of major
    • cardiovascular and nonvascular mortality, JAMA 294 (2005) 1799-1809. [8] P. Willeit, A. Thompson, T. Aspelund, A. Rumley, G. Eiriksdottir, G. Lowe, V.
    • One 8 (2013) e55175. [9] S.G. Wannamethee, P.H. Whincup, A.G. Shaper, A. Rumley, L. Lennon, G.D.O. Lowe,
    • J. Throm. Haemost. 7 (2009) 1605-1611. [10] G.D.O. Lowe, A. Rumley, M. Woodward, E. Reid, J. Rumley, Activated protein c
    • resistance and the FV:R506 Q mutation in a random population sample, Thromb.
    • Haemost. 81 (1999) 918-924. [11] A.G. Shaper, S.J. Pocock, M. Walker, N.M. Cohen, C.J. Wale, A.G. Thomson, British
    • Regional Heart Study:cardiovascular risk factors in middle aged men in 24 towns,
    • BMJ 283 (1981) 179-186. [12] S.G. Wannamethee, A.G. Shaper, P.H. Whincup, L. Lennon, N. Sattar, Obesity and risk
    • disease: does leptin have a role? J. Am. Coll. Cardiol. 58 (2011) 1870-1877. [13] S.G. Wannamethee, G.D.O. Lowe, P.H. Whincup, A. Rumley, M. Walker, L. Lennon,
    • Circulation 105 (2002) 1785-1790. [14] A.S. Levy, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, D.A. Roth, More accurate method
    • equation. Modification of diet in renal disease study group, Ann. Intern. Med. 130
    • (1999) 461-470. [15] S.G. Wannamethee, P. Welsh, P. Whincup, L. Lennon, O. Papacosta, N. Sattar,
    • without cardiovascular disease: population-based study, Eur. J. Heart Fail. 16
    • (2014) 25-32. [16] M. Walker, A.G. Shaper, L. Lennon, P.H. Whincup, Twenty year follow-up of a cohort
    • study based in general practices in 24 British towns, J. Public Health Med. 22 (2000)
    • 479-485. [17] P. Ponikowski, A.A. Voors, S.D. Anker, H. Bueno, J.G. Cleland, A.J. Coats, V. Falk, J.R.
    • Reviewers, 2016 ESC guidelines for the diagnosis and treatment of acute and
    • Eur. J. Heart Fail. 18 (2016) 891-975. [18] S.G. Wannamethee, P.H. Whincup, L. Lennon, O. Papacosta, G.D. Lowe, Associations
    • limitation, and all-cause mortality in older men, J. Am. Geriatr. Soc. 62 (2014)
    • 2357-2362. [19] S.G. Wannamethee, P.H. Whincup, L. Lennon, A. Rumley, G.D. Lowe, Fibrin D-dimer,
    • in older men, Stroke 43 (2012) 1206-1211. [20] S.T. Loubele, C.A. Spek, P. Leenders, R. van Oerle, H.L. Aberson, K. Hamulyák, G.
    • inflammation, Arterioscler. Thromb. Vasc. Biol. 29 (2009) 1087-1092. [21] M.J. Sopel, N.L. Rosin, A.G. Falkenham, M. Bezuhly, C.T. Esmon, T.D. Lee, R.S. Liwski,
    • PLoS One 7 (2012) e45663. [22] K. Kaila, M.J. Haykowsky, R.B. Thompson, D.I. Paterson, Heart failure with preserved
    • ejection fraction in the elderly:scope of the problem, Heart Fail. Rev. 17 (2012)
    • 555-562. [23] F.P. Brouwers, R.A. de Boer, P. van der Harst, A.A. Voors, R.T. Gansevoort, S.J. Bakker,
    • based cohort: 11-year follow-up of PREVEND, Eur. Heart J. 34 (2013) 1424-1431. [24] E. Shantsila, G.Y.H. Lip, The endothelium and thrombotic risk in heart failure,
    • Thromb. Haemost. 102 (2009) 185-187. [25] F. Zannad, W.G. Stough, V. Regnault, M. Gheorghiade, E. Deliargyris, C.M. Gibson, S.
    • challenges, Int. J. Cardiol. 167 (2013) 1772-1782. [26] C. Hall, NT-ProBNP: the mechanism behind the marker, J. Card. Fail. 11 (2005)
    • S81-S83. [27] U. Alegan, U. Dahlstrom, T.L. Lindahl, Low plasma concentrations of coagulation
    • failure, Blood Coagul. Fibrinolysis 21 (2010) 62-69. [28] G.Y. Lip, C. Laroche, M.I. Popescu, L.H. Rasmussen, L. Vitali-Serdoz, G.A. Dan, Z.
    • Research Programme Pilot survey on Atrial Fibrillation, Eur. J. Heart Fail. 17
  • Inferred research data

    The results below are discovered through our pilot algorithms. Let us know how we are doing!

    Title Trust
  • Discovered through pilot similarity algorithms. Send us your feedback.